All In MedTech

Device Trial Radar · NCT05741723

OCS DCD Heart + CAP Continued Follow-Up

OCS DCD Heart + CAP Continued Follow-Up Post-Approval Study

Last checked: Nov 20, 2026Latest source record: Sep 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

276

Planned (sponsor's estimate)

Start

Nov 26, 2019

Primary completion

Oct 2026

Study completion Oct 2026

Sponsor

Lead sponsor
TransMedicsNot on our public-company list
Sponsor type
Industry
First posted
Feb 23, 2023

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years

Summary

As written by the sponsor on the registry.

The objective of this post-approval study is to evaluate long-term outcomes of patients enrolled in the OCS DCD Heart and OCS DCD Heart CAP studies.

Conditions

  • Heart Transplant

Interventions

  • OCS HeartDevice

    Transplanted with OCS preserved heart.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Patient survivalTime frame: 5 years post-transplant

Locations

20 sites in 1 country. Site status is shown where the registry gives one.

  • University of California San Diago

    La Jolla, California

19 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.